| Aptamer ID | Aptamer descriptor | Target chemistry | Target name | Affinity | Binding Conditions/Buffer | PubMed ID |
|---|---|---|---|---|---|---|
| Apta_723 | N | Molecule | Valine | 12 mM | 25 mM HEPES, 200 mM NaCl, 6 mM MgCl2, 1 mM EDTA (pH 7.3) | 7545073 |
| Aptamer Sequence: | GGGAGCUCAGAAUAAACGCUCAAAUCCGUGGACAGGGCGUAAGCGCCUUCGACAUGAGACACGGAUCCUGCGACGAAUUCAGC |
| The optimal secondary structure in dot-bracket notation: | ....(((..((((...(((....(((((((..(((((((....)))))......))...)))))))...)))....))))))) |
| The centroid secondary structure in dot-bracket notation: | ....(((..((((...(((....(((((((....(((((....)))))...........)))))))...)))....))))))) |
| Type | Detail | Type | Detail |
|---|---|---|---|
| Aptamer ID | Apta_723 | Description | N |
| Aptamer chemistry | RNA | Length | 83 nt |
| GC content | 55.4% | Molecular weight | 26,818.06 Da |
| Molarity of 1 μg/μl solution | 37.29 μM | Number of G-quadruplexes | No QGRS found |
| G-Score | N/A | Function | Targeted binding |
| Sequence | GGGAGCUCAGAAUAAACGCUCAAAUCCGUGGACAGGGCGUAAGCGCCUUCGACAUGAGACACGGAUCCUGCGACGAAUUCAGC | ||
| Applications | Binding to valine | ||
| Type | Detail | Type | Detail |
|---|---|---|---|
| PubChem ID | 6287 | Molecular name | Valine |
| Molecular formula | C5H11NO2 | Molecular weight | 117.15 |
| IUPAC name | (2S)-2-amino-3-methylbutanoic acid | InChIKey | KZSNJWFQEVHDMF-BYPYZUCNSA-N |
| LogP | 0.054 | Topological polar surface area | 63.32 |
| Hydrogen bond acceptor | 2 | Hydrogen bond donor | 2 |
Synonym(s): L-valine; valine; 72-18-4; (S)-Valine; H-Val-OH; (S)-2-Amino-3-methylbutanoic acid; 2-Amino-3-methylbutyric acid; (2S)-2-amino-3-methylbutanoic acid; (S)-2-Amino-3-methylbutyric acid; L-alpha-Amino-beta-methylbutyric acid; Valinum [Latin]; Valina [Spanish]; Valine (VAN); Butanoic acid, 2-amino-3-methyl-; Valine [USAN:INN]; L-valin; VALINE, L-; L(+)-alpha-Aminoisovaleric acid; (S)-alpha-Amino-beta-methylbutyric acid; Butanoic acid, 2-amino-3-methyl-, (S)-; 2-Amino-3-methylbutyric acid, (S)-; 2-Amino-3-methylbutanoic acid, (S)-; UNII-HG18B9YRS7; NSC 76038; (L)-valine; 2-Amino-3-methylbutanoic acid (VAN); 7004-03-7; CHEBI:16414; L-2-Amino-3-methylbutanoic acid; l-(+)-alpha-Aminoisovaleric acid; L-2-Aminoisovaleric Acid; MFCD00064220; val; valina; HG18B9YRS7; (S)-alpha-Aminoisovaleric acid; NSC-76038; Valine (L-Valine); L-Val; Valinum; 2-aminoisovaleric acid; (2S)-2-amino-3-methylbutanoate; alpha-aminoisovaleric acid; EINECS 200-773-6; 2-Amino-3-methyl-butyric acid; 2-amino-3-methylbutanoate; Racemic valine; L-(+)-a-Aminoisovaleric acid; s-valin; L-(+)-.alpha.-Aminoisovaleric acid; L-a-Amino-b-methylbutyric acid; HSDB 7800; 3h-l-valine; (S)-a-Amino-b-methylbutyric acid; L-Valine;; L-Valine, FCC; Valine (USP); (+)-valine; L-Valine,(S); 1t4s; L-Valine (JP17); L-Valine, 99%; (S)-Val; L-Val-4; L-VAL-OH; 2-Amino-3-methylbutyrate; bmse000052; bmse000811; bmse000860; EC 200-773-6; L-(+)-a-Aminoisovalerate; L-a-Amino-b-methylbutyrate; SCHEMBL8516; (S)-A-Aminoisovaleric acid; H-Val-2-Chlorotrityl Resin; (S)-?-Aminoisovaleric acid; 2-Aminoisovaleric acid,(S); CHEMBL43068; (S)-a-Amino-b-methylbutyrate; L-(+)-alpha-Aminoisovalerate; L-iso-C3H7CH(NH2)COOH; GTPL4794; (S)-2-Amino-3-methylbutyrate; (S)-2-Amino-3-methylbutanoate; L-Valine, Cell Culture Reagent; DTXSID40883233; L-alpha-Amino-beta-methylbutyrate; (S)-2-amino-3-methyl-Butanoate; Pharmakon1600-01301009; ZINC895099; HY-N0717; (S)-alpha-Amino-beta-methylbutyrate; (S)-2-amino-3-methyl-butyric acid; BDBM50463208; NSC760111; s5628; (S)-2-amino-3-methyl-Butanoic acid; L-Valine, 98.5-101.5%; AKOS015841564; AM82363; CCG-266067; CS-W020706; DB00161; L-Valine, 99%, natural, FCC, FG; MCULE-9143825935; NSC-760111; NCGC00344520-01; AS-12787; K180; L-Valine, BioUltra, >=99.5% (NT); L-Valine, SAJ special grade, >=98.5%; AB0014076; DB-029989; L-Valine, reagent grade, >=98% (HPLC); L-Valine, Vetec(TM) reagent grade, >=98%; C00183; D00039; M02950; V-1800; (S)-(+)-2-AMINO-3-METHYLBUTYRIC ACID; 064V220; 192321-EP2272829A2; Q483752; Q-100919; L-Valine, certified reference material, TraceCERT(R); F8889-8698; Valine, European Pharmacopoeia (EP) Reference Standard; Z1250208665; 1B39571B-0AE8-4A9A-AE80-4B898D11A981; L-Valine, dimer, meets the analytical specifications of USP; UNII-0O72R8RF8A component KZSNJWFQEVHDMF-BYPYZUCNSA-N; UNII-4CA13A832H component KZSNJWFQEVHDMF-BYPYZUCNSA-N; UNII-66PZQ62YA6 component KZSNJWFQEVHDMF-BYPYZUCNSA-N; UNII-N7U7BXP2OI component KZSNJWFQEVHDMF-BYPYZUCNSA-N; L-Valine, United States Pharmacopeia (USP) Reference Standard; L-Valine, Pharmaceutical Secondary Standard; Certified Reference Material; L-Valine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%; L-Valine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
|
No relevant experimental diagram |
Interaction ID | 802 |
| Target type | Molecule | |
| Target unique ID | 6287 | |
| Activity | 12 mM | |
| Binding Conditions/Buffer | 25 mM HEPES, 200 mM NaCl, 6 mM MgCl2, 1 mM EDTA (pH 7.3) |
|
| Assay | N/A |
|
| PubMed ID | 7545073 |
| Aptamer ID | Aptamer chemistry | Sequence | Similarity |
|---|---|---|---|
| Apta_171 | RNA | GGGAGCUCAGAAUAAACGCUCAACCAGUCUUGUGGCUUUGAAAGAGAGGAGUGUUCGACAUGAGGCCCGGAUCCGGC | |
| Apta_432 | RNA | GGGAGACAAGAAUAAACGCUCAAGGCAUUUCUGCUAGUCUGGUUGUAAGAUAUUCAACACGUGAGUUUCGACAGGAGGCUCACAACAGGC | |
| Apta_854 | RNA | GGGAGCUCAGAAUAAACGCUCAAGGGUAGGGAUCGUUACCCCGACAUUUUAAUGGGCCGAUGUUUCGACAUGAGGCCCGGAUCCGGC | |
| Apta_433 | RNA | GGGAGACAAGAAUAAACGCUCAACGUUCAGUAUAACAGUCCGAGUCUAACACACAAUGGGACACUGAAUUCGACAGGAGGCUCACAACAGGC | |
| Apta_137 | RNA | GGGAGACAAGAAUAAACGCUCAAGUGACGUCCUGAUCGAUUGUGCAUUCGGUGUGACGAUCUUUCGACAGGAGGCUCACAACAGGC | |
| Apta_398 | RNA | GGGAGGACGAUGCGGCUUUAAUCCUCGCACUCAGCGCGCAUCACCCUUGACAUCACAGACGACUCGCUGAGGAUCCGAGA | |
| Apta_256 | RNA | GGGCGCUAAGUCCUCGCUCAUGCGCGUCCCAUGGGGUAUAGAGGGGUCGAAGUGGACGCGCGACUCGGAUCCU | |
| Apta_502 | DNA | GGGAGACAAGAATAAACGCTCAAATGGACTTTTGAATGTGGCAACAAATTCGACAGGAGGCTCACAACAGGC | |
| Apta_790 | DNA | GGGAGACAAGAATAAACGCTCAAGAAGTGAAAATGACAGAACACAACATTCGACAGGAGGCTCACAACAGGC | |
| Apta_886 | RNA | GGGAGACGAUAUUCGUCCAUUCGGGUGGCCCGUGUCUGAGCGGGGACGGCCACUUGAGCGCCGCUGUCCGACUGAAUUCUCGACC | |
| Apta_272 | RNA | GGGAGACAAGAAUAAACGCUCAACACAGAACGCGGUCCCCACACAGGACAGGAGCCAGCCCCGGUUCGACAGGAGGCUCACAACAGGC | |
| Apta_170 | RNA | GGGAGACAAGACUAGACGCUCAAUGUGGGCCACGCCCGAUUUUACGCUUUUACCCGCACGCGAUUGGUUUGUUUCCC | |
| Apta_305 | RNA | GGGAGGACGAUGCGGAUCGCCCUGAACCGGCCCAGCAGACUGCUGACGGCACGAUCCGCAUCGUCCUCCC | |
| Apta_1223 | RNA | GGAGGCGCCAACUGAAUGAAAGGUUACGCUUCAACGCCGUGCAGCUGCUUCGGCAGGCUUGUGAGUACAUGGCCCAUUGAUCCGUAACUAGUCGCGUCAC | |
| Apta_1222 | RNA | GGAGGCGCCAACUGAAUGAAACCGUGCUAAGGAGUUGGACUCCGCUGCUUCGGCAGAGCGAUAUAGUGCCAGCUGAUACAUCCGUAACUAGUCGCGUCAC | |
| Apta_1224 | RNA | GGAGGCGCCAACUGAAUGAAUGUUCUGGAUCUGCUAGAGACUAUCUGCUUCGGCAGCACUCUCCGUUAACAACACGUACAUCCGUAACUAGUCGCGUCAC | |
| Apta_936 | RNA | GGAGCUCAGCCUUCACUGCGAUCACCGUGUCGGUGGCUAGUCGAUGUAUCCCGAUCACCAUUGGGGGCAAGUUUAGACAGGCACCACGGUCGGAUCCAC | |
| Apta_123 | RNA | GGGAGAAAGGGAAGCUUGAGCAGCAGGAGGGCCGGCGUUAGGGUUAGCGAGCCGAUUGAAAGAAGAAGGAACGAGCGUACGGAUCCGAUC | |
| Apta_380 | RNA | GGGAUGCUUCGGCAUCCCCGAAGCCGCUAUGGACCAGUGGCGCGGCUUCGGCCCGACGGAGUGGUACCGCUUCGGCGGUACGUAAGCUUGGG | |
| Apta_397 | RNA | GGGAGGACGAUGCGGAUACCAGGAUCACAUCCUGAGGAACCCCGGCUCCCAACCUCAGACGACUCGCUGAGGAUCCGAGA |